AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
REVISED NUCLEAR REGULATORY COMMISSION REGULATIONS FOR RELEASE OF PATIENTS ADMINISTERED RADIOACTIVE MATERIALS - OUTPATIENT I-131 ANTI-B1 THERAPY
Authors: SIEGEL JA
Citation: Ja. Siegel, REVISED NUCLEAR REGULATORY COMMISSION REGULATIONS FOR RELEASE OF PATIENTS ADMINISTERED RADIOACTIVE MATERIALS - OUTPATIENT I-131 ANTI-B1 THERAPY, The Journal of nuclear medicine, 39(8), 1998, pp. 28-33
NONMYELOABLATIVE I-131 ANTI-B1 RADIOIMMUNOTHERAPY AS OUTPATIENT THERAPY
Authors: GATES VL CAREY JE SIEGEL JA KAMINSKI MS WAHL RL
Citation: Vl. Gates et al., NONMYELOABLATIVE I-131 ANTI-B1 RADIOIMMUNOTHERAPY AS OUTPATIENT THERAPY, The Journal of nuclear medicine, 39(7), 1998, pp. 1230-1236
RADIATION ABSORBED DOSE ESTIMATES FOR INDIUM-111-LABELED B72.3, AN IGG ANTIBODY TO OVARIAN AND COLORECTAL-CANCER - MIRD DOSE ESTIMATE REPORT NO. 18
Authors: MARDIROSSIAN G BRILL AB HARWOOD SJ OLSEN J DWYER KA SIEGEL JA
Citation: G. Mardirossian et al., RADIATION ABSORBED DOSE ESTIMATES FOR INDIUM-111-LABELED B72.3, AN IGG ANTIBODY TO OVARIAN AND COLORECTAL-CANCER - MIRD DOSE ESTIMATE REPORT NO. 18, The Journal of nuclear medicine, 39(4), 1998, pp. 671-676
DYNAMIC DISTRIBUTION AND DOSIMETRIC EVALUATION OF HUMAN NONSPECIFIC IMMUNOGLOBULIN-G LABELED WITH IN-111 OR TC-99(M)
Authors: BUIJS WCAM OYEN WJG DAMS ETM BOERMAN OC SIEGEL JA CLAESSENS RAMJ VANDERMEER JWM CORSTENS FHM
Citation: Wcam. Buijs et al., DYNAMIC DISTRIBUTION AND DOSIMETRIC EVALUATION OF HUMAN NONSPECIFIC IMMUNOGLOBULIN-G LABELED WITH IN-111 OR TC-99(M), Nuclear medicine communications, 19(8), 1998, pp. 743-751
PHASE I II CLINICAL RADIOIMMUNOTHERAPY WITH AN IODINE-131-LABELED ANTICARCINOEMBRYONIC ANTIGEN MURINE MONOCLONAL-ANTIBODY IGG/
Authors: BEHR TM SHARKEY RM JUWEID ME DUNN RM VAGG RC YING ZL ZHANG CH SWAYNE LC VARDI Y SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., PHASE I II CLINICAL RADIOIMMUNOTHERAPY WITH AN IODINE-131-LABELED ANTICARCINOEMBRYONIC ANTIGEN MURINE MONOCLONAL-ANTIBODY IGG/, The Journal of nuclear medicine, 38(6), 1997, pp. 858-870
RED MARROW DOSIMETRY AFTER ADMINISTRATION OF I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY (CG250) IN PATIENTS WITH RENAL-CELL CARCINOMA,BASED ON PLANAR GAMMA-CAMERA IMAGES
Authors: BUIJS WCAM STEFFENS MG BOERMAN O SIEGEL JA OOSTERWIJK E CORSTENS FHM
Citation: Wcam. Buijs et al., RED MARROW DOSIMETRY AFTER ADMINISTRATION OF I-131-LABELED CHIMERIC G250 MONOCLONAL-ANTIBODY (CG250) IN PATIENTS WITH RENAL-CELL CARCINOMA,BASED ON PLANAR GAMMA-CAMERA IMAGES, The Journal of nuclear medicine, 38(5), 1997, pp. 958-958
COMPARISON OF POINT-SOURCE AND MONTE-CARLO METHODS IN DETERMINING DOSE PER UNIT CUMULATED ACTIVITY FROM EXPOSURE TO PATIENTS ADMINISTERED RADIOACTIVE MATERIAL
Authors: SPARKS RB SIEGEL JA
Citation: Rb. Sparks et Ja. Siegel, COMPARISON OF POINT-SOURCE AND MONTE-CARLO METHODS IN DETERMINING DOSE PER UNIT CUMULATED ACTIVITY FROM EXPOSURE TO PATIENTS ADMINISTERED RADIOACTIVE MATERIAL, The Journal of nuclear medicine, 38(5), 1997, pp. 968-968
VARIABLES INFLUENCING TUMOR DOSIMETRY IN RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS WITH ANTI-CEA AND ANTIMUCIN MONOCLONAL-ANTIBODIES
Authors: BEHR TM SHARKEY RM JUWEID ME DUNN RM YING ZL ZHANG CH SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., VARIABLES INFLUENCING TUMOR DOSIMETRY IN RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS WITH ANTI-CEA AND ANTIMUCIN MONOCLONAL-ANTIBODIES, The Journal of nuclear medicine, 38(3), 1997, pp. 409-418
CLINICAL FUSION OF 3-DIMENSIONAL IMAGES USING BREMSSTRAHLUNG SPECT AND CT
Authors: PARSAI EI AYYANGAR KM DOBELBOWER RR SIEGEL JA
Citation: Ei. Parsai et al., CLINICAL FUSION OF 3-DIMENSIONAL IMAGES USING BREMSSTRAHLUNG SPECT AND CT, The Journal of nuclear medicine, 38(2), 1997, pp. 319-324
CONTRIBUTION OF GASTRIC AND POSTGASTRIC FEEDBACK TO SATIATION AND SATIETY IN WOMEN
Authors: SPIEGEL TA HUBERT CD FRIED H PEIKIN SR SIEGEL JA ZEIGER LS
Citation: Ta. Spiegel et al., CONTRIBUTION OF GASTRIC AND POSTGASTRIC FEEDBACK TO SATIATION AND SATIETY IN WOMEN, Physiology & behavior, 62(5), 1997, pp. 1125-1136
DOSIMETRY OVERVIEW - KEEPING SCORE ON THE SCOREKEEPERS
Authors: WESSELS BW SIEGEL JA
Citation: Bw. Wessels et Ja. Siegel, DOSIMETRY OVERVIEW - KEEPING SCORE ON THE SCOREKEEPERS, Cancer, 80(12), 1997, pp. 2501-2504
OVERCOMING THE NEPHROTOXICITY OF RADIOMETAL-LABELED IMMUNOCONJUGATES - IMPROVED CANCER-THERAPY ADMINISTERED TO A NUDE-MOUSE MODEL IN RELATION TO THE INTERNAL RADIATION-DOSIMETRY
Authors: BEHR TM SHARKEY RM SGOUROS G BLUMENTHAL RD DUNN RM KOLBERT K GRIFFITHS GL SIEGEL JA BECKER WS GOLDENBERG DM
Citation: Tm. Behr et al., OVERCOMING THE NEPHROTOXICITY OF RADIOMETAL-LABELED IMMUNOCONJUGATES - IMPROVED CANCER-THERAPY ADMINISTERED TO A NUDE-MOUSE MODEL IN RELATION TO THE INTERNAL RADIATION-DOSIMETRY, Cancer, 80(12), 1997, pp. 2591-2610
SELECTIVE TUMOR-IRRADIATION BY INFUSIONAL BRACHYTHERAPY IN NONRESECTABLE PANCREATIC-CANCER - A PHASE-I STUDY
Authors: ORDER SE SIEGEL JA PRINCIPATO R ZEIGER LE JOHNSON E LANG P LUSTIG R WALLNER PE
Citation: Se. Order et al., SELECTIVE TUMOR-IRRADIATION BY INFUSIONAL BRACHYTHERAPY IN NONRESECTABLE PANCREATIC-CANCER - A PHASE-I STUDY, International journal of radiation oncology, biology, physics, 36(5), 1996, pp. 1117-1126
FACTORS INFLUENCING THE PHARMACOKINETICS, DOSIMETRY AND DIAGNOSTIC-ACCURACY IN RADIOIMMUNODETECTION AND THERAPY OF CEA-EXPRESSING TUMORS
Authors: BEHR TM SHARKEY RM JUWEID ME DUNN RM YING Z SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., FACTORS INFLUENCING THE PHARMACOKINETICS, DOSIMETRY AND DIAGNOSTIC-ACCURACY IN RADIOIMMUNODETECTION AND THERAPY OF CEA-EXPRESSING TUMORS, The Journal of nuclear medicine, 37(5), 1996, pp. 27-27
DOSIMETRIC POTENTIAL OF MINIMAL RESIDUAL DISEASE USING RADIOLABELED ANTIBODIES
Authors: DUNN RM JUWEID M BEHR TM SIEGEL JA SHARKEY RM GOLDENBERG DM
Citation: Rm. Dunn et al., DOSIMETRIC POTENTIAL OF MINIMAL RESIDUAL DISEASE USING RADIOLABELED ANTIBODIES, The Journal of nuclear medicine, 37(5), 1996, pp. 167-167
3-DIMENSIONAL QUANTITATIVE DOSIMETRY OF COLLOIDAL P-32 USING IMAGES OBTAINED FROM BREMSSTRAHLUNG SPECT
Authors: AYYANGAR KM PARSAI EI DOBELBOWER RR SIEGEL JA
Citation: Km. Ayyangar et al., 3-DIMENSIONAL QUANTITATIVE DOSIMETRY OF COLLOIDAL P-32 USING IMAGES OBTAINED FROM BREMSSTRAHLUNG SPECT, The Journal of nuclear medicine, 37(5), 1996, pp. 349-349
Y-90 DOSIMETRY IN NUDE-MICE REQUIRES ACCOUNTING FOR CROSS-ORGAN RADIATION - EVALUATION OF 3 DOSIMETRIC MODELS IN RELATION TO OBSERVED BIOLOGICAL EFFECTS
Authors: BEHR TM SGOUROS G SHARKEY RM DUNN RM BLUMENTHAL RD KOLBERT K SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., Y-90 DOSIMETRY IN NUDE-MICE REQUIRES ACCOUNTING FOR CROSS-ORGAN RADIATION - EVALUATION OF 3 DOSIMETRIC MODELS IN RELATION TO OBSERVED BIOLOGICAL EFFECTS, The Journal of nuclear medicine, 37(5), 1996, pp. 400-400
RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS - RESULTS OF A PHASE-I II STUDY WITH AN I-131-LABELED ANTI-CEA MONOCLONAL IGG(1)/
Authors: BEHR TM SHARKEY RM JUWEID ME DUNN RM VAGG RC SWAYNE LC YING Z SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS - RESULTS OF A PHASE-I II STUDY WITH AN I-131-LABELED ANTI-CEA MONOCLONAL IGG(1)/, The Journal of nuclear medicine, 37(5), 1996, pp. 734-734
TUMOR DOSIMETRY IN THE RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS WITH I-131-LABELED MURINE AND HUMANIZED ANTI-CEA AND ANTI-MUCIN MONOCLONAL-ANTIBODIES
Authors: BEHR TM SHARKEY RM DUNN RM JUWEID ME YING Z SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., TUMOR DOSIMETRY IN THE RADIOIMMUNOTHERAPY OF CEA-EXPRESSING CANCERS WITH I-131-LABELED MURINE AND HUMANIZED ANTI-CEA AND ANTI-MUCIN MONOCLONAL-ANTIBODIES, The Journal of nuclear medicine, 37(5), 1996, pp. 1043-1043
REGIONAL RADIOACTIVITY QUANTITATION BASED ON SPECT
Authors: DUNN RM JUWEID M BEHR TM SIEGEL JA SHARKEY RM GOLDENBERG DM
Citation: Rm. Dunn et al., REGIONAL RADIOACTIVITY QUANTITATION BASED ON SPECT, The Journal of nuclear medicine, 37(5), 1996, pp. 1048-1048
BODY CONTOUR DETERMINATION AND VALIDATION FOR BREMSSTRAHLUNG SPECT IMAGING
Authors: SIEGEL JA KHAN SH
Citation: Ja. Siegel et Sh. Khan, BODY CONTOUR DETERMINATION AND VALIDATION FOR BREMSSTRAHLUNG SPECT IMAGING, The Journal of nuclear medicine, 37(3), 1996, pp. 495-497
THYROID RADIATION-DOSES DURING RADIOIMMUNOTHERAPY OF CEA-EXPRESSING TUMORS WITH I-131-LABELED MONOCLONAL-ANTIBODIES
Authors: BEHR TM JUWEID ME SHARKEY RM DUNN RM YING Z BECKER WS SIEGEL JA GOLDENBERG DM
Citation: Tm. Behr et al., THYROID RADIATION-DOSES DURING RADIOIMMUNOTHERAPY OF CEA-EXPRESSING TUMORS WITH I-131-LABELED MONOCLONAL-ANTIBODIES, Nuclear medicine communications, 17(9), 1996, pp. 767-780
PHYSEAL REACTIONS TO ABSORBABLE BONE PINS
Authors: SIEGEL JA CADY RB SPADARO JA MATHIAN G CHASE SE
Citation: Ja. Siegel et al., PHYSEAL REACTIONS TO ABSORBABLE BONE PINS, Pediatrics, 98(3), 1996, pp. 28-28
FACTORS INFLUENCING THE PHARMACOKINETICS, DOSIMETRY, AND DIAGNOSTIC-ACCURACY OF RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CARCINOEMBRYONIC ANTIGEN-EXPRESSING TUMORS
Authors: BEHR TM SHARKEY RM JUWEID MI DUNN RM YING ZL ZHANG CH SIEGEL JA GOLD DV GOLDENBERG DM
Citation: Tm. Behr et al., FACTORS INFLUENCING THE PHARMACOKINETICS, DOSIMETRY, AND DIAGNOSTIC-ACCURACY OF RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CARCINOEMBRYONIC ANTIGEN-EXPRESSING TUMORS, Cancer research, 56(8), 1996, pp. 1805-1816
CLINICAL-EVALUATION OF TUMOR TARGETING WITH THE ANTICARCINOEMBRYONIC ANTIGEN MURINE MONOCLONAL-ANTIBODY FRAGMENT, MN-14 F(AB)(2)
Authors: JUWEID M SHARKEY RM BEHR TM SWAYNE LC DUNN R YING ZL SIEGEL JA HANSEN HJ GOLDENBERG DM
Citation: M. Juweid et al., CLINICAL-EVALUATION OF TUMOR TARGETING WITH THE ANTICARCINOEMBRYONIC ANTIGEN MURINE MONOCLONAL-ANTIBODY FRAGMENT, MN-14 F(AB)(2), Cancer, 78(1), 1996, pp. 157-168
Risultati: 1-25 | 26-42